Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytosorbents Corporation - Common Stock
(NQ:
CTSO
)
0.6600
+0.0220 (+3.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytosorbents Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
September 19, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
September 11, 2023
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survival
From
CytoSorbents
Via
GlobeNewswire
A Preview Of CytoSorbents's Earnings
↗
May 01, 2023
Via
Benzinga
Looking Into CytoSorbents's Return On Capital Employed
↗
March 13, 2023
Via
Benzinga
CytoSorbents Earnings Preview
↗
March 08, 2023
Via
Benzinga
CytoSorbents's Return On Capital Employed Overview
↗
November 21, 2022
Via
Benzinga
Brady, America's Car-Mart And 3 Stocks To Watch Heading Into Tuesday
↗
September 05, 2023
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
September 01, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
August 31, 2023
Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery Patients
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
August 01, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
July 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
July 19, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
July 11, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
July 07, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
June 05, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports First Quarter 2023 Results
May 02, 2023
Pivotal U.S. and Canada STAR-T Trial enrollment enters the last third of the study. Strong customer demand from Q4 2022 continued into Q1 2023, with current expectation of overall sales growth in 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
April 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
April 20, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
April 19, 2023
From
CytoSorbents
Via
GlobeNewswire
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
March 29, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
March 22, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
March 14, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
March 09, 2023
From
CytoSorbents
Via
GlobeNewswire
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
March 07, 2023
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 03, 2023
Via
Benzinga
Why Cytosorbents Shares Are Popping Off Thursday
↗
December 29, 2022
Cytosorbents Corp (NASDAQ: CTSO) shares are trading higher by 15.55% to $1.38 Thursday afternoon after the company announced it received $5 million in non-dilutive debt financing from Bridge Bank and...
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
↗
November 04, 2022
Gainers
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
↗
November 07, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 04, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
